Literature DB >> 29221726

miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.

Likun Yan1, Jianfeng Yao2, Jian Qiu2.   

Abstract

microRNAs (miRNAs) have been reported to play crucial roles in malignant tumor progression, including cell development, proliferation, and progression. Increasing evidence suggests that miR-495 functions as either an oncogene or tumor suppressor in several tumor types. However, its biological role in the development of colorectal cancer (CRC) still remains unclear. In this study, we found that miR-495 expression level was remarkably down-regulated in CRC tissues samples and cell lines when compared to adjacent normal tissues and cell line by using qRT-PCR detection. Ectopic expression of miR-495 by mimic transfection significantly suppressed CRC cell proliferation and colony formation, inhibited migration and invasion, and induced apoptosis according to CCK-8, colony formation, transwell, and flow cytometry assays. Furthermore, bioinformatics and luciferase reporter assays verified that family with sequence similarity 83, member D (FAM83D) was a direct target of miR-495 in CRC cells, and FAM83D was confirmed to be upregulated in human CRC tissues and reversely correlated with miR-495 expression. In addition, rescue experiments revealed that restoration of FAM84D could partially abrogate the inhibitory effect of miR-495 overexpression on CRC cell proliferation and metastasis. Further mechanic investigations also verified that the PTEN/P13K/AKT/mTOR pathway was involved in the miR-495/FAM83D-mediated CRC cell progression. Our findings identified that miR-495 acted as a critical tumor suppressor by directly targeting FAM83D during CRC development and therefore represented as a potential biomarker for CRC therapy.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; FAM83D; Proliferation; Tumor suppressor; miR-495

Mesh:

Substances:

Year:  2017        PMID: 29221726     DOI: 10.1016/j.biopha.2017.11.138

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  20 in total

1.  MicroRNA-126 exerts antitumor functions in ovarian cancer by targeting EGFL7 and affecting epithelial-to-mesenchymal transition and ERK/MAPK signaling pathway.

Authors:  Yuhua Zhang; Xiaobo Qin; Juan Jiang; Wenjie Zhao
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

2.  FAM83D is associated with gender, AJCC stage, overall survival and disease-free survival in hepatocellular carcinoma.

Authors:  Xuling Liu; Hong Gao; Jie Zhang; Dongying Xue
Journal:  Biosci Rep       Date:  2019-05-07       Impact factor: 3.840

Review 3.  Enhanced Inhibition of Tumorigenesis Using Combinations of miRNA-Targeted Therapeutics.

Authors:  Svetlana Miroshnichenko; Olga Patutina
Journal:  Front Pharmacol       Date:  2019-05-16       Impact factor: 5.988

4.  Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach.

Authors:  Precious Takondwa Makondi; Po-Li Wei; Chien-Yu Huang; Yu-Jia Chang
Journal:  PLoS One       Date:  2019-02-26       Impact factor: 3.240

5.  miR-496, miR-1185, miR-654, miR-3183 and miR-495 are downregulated in colorectal cancer cells and have putative roles in the mTOR pathway.

Authors:  Naif Alqurashi; Saeed M Hashimi; Faisal Alowaidi; Saso Ivanovski; Amro Farag; Ming Q Wei
Journal:  Oncol Lett       Date:  2019-06-21       Impact factor: 2.967

6.  miR-148a inhibits cell proliferation and migration through targeting ErbB3 in colorectal cancer.

Authors:  Wei Zhao; Jianbao Zheng; Guangbing Wei; Kui Yang; Guanghui Wang; Xuejun Sun
Journal:  Oncol Lett       Date:  2019-07-05       Impact factor: 2.967

7.  Genome-wide analysis to identify a novel microRNA signature that predicts survival in patients with stomach adenocarcinoma.

Authors:  Shan-Shan Luo; Xi-Wen Liao; Xiao-Dong Zhu
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

Review 8.  Epigenetic Regulation by lncRNAs: An Overview Focused on UCA1 in Colorectal Cancer.

Authors:  Bernadette Neve; Nicolas Jonckheere; Audrey Vincent; Isabelle Van Seuningen
Journal:  Cancers (Basel)       Date:  2018-11-14       Impact factor: 6.639

9.  LINC00491 as a new molecular marker can promote the proliferation, migration and invasion of colon adenocarcinoma cells.

Authors:  Jiahui Wan; Daiqian Deng; Xiuli Wang; Xiaojin Wang; Shijun Jiang; Rongjun Cui
Journal:  Onco Targets Ther       Date:  2019-08-13       Impact factor: 4.147

10.  circFOXM1 promotes proliferation of non-small cell lung carcinoma cells by acting as a ceRNA to upregulate FAM83D.

Authors:  Chengtao Yu; Zhuoan Cheng; Shaohua Cui; Xiaowei Mao; Botai Li; Yujie Fu; Hui Wang; Haojie Jin; Qing Ye; Xiaojing Zhao; Liyan Jiang; Wenxin Qin
Journal:  J Exp Clin Cancer Res       Date:  2020-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.